ArticleCancer chemotherapy and pharmacology2014

Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102.

John M Fidler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.